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Intrauterine growth restriction (IUGR) complicates up to 15% of 
pregnancies and often occurs in conjunction with exposure to a maternal diet 
high in saturated fats (HFD). IUGR is associated with alterations to the structure 
and development of the lung. Lung development depends upon the precise and 
coordinate expression of genetic and epigenetic determinants. Methylation of 
lysine 20 on histone 4 (H4K20Me) is an epigenetic histone modification of 
interest in lung development. The enzyme Setd8 places the H4K20Me mark 
along target genes, including the PPARγ gene. The H4K20Me mark increases 
transcription of PPARγ mRNA and production of the translated product, PPARγ 
protein. By way of a feedback loop, PPARγ is also the transcription factor that 
regulates transcription of Setd8. PPARγ is critical in alveolarization, or the final 
stage in lung development.  We previously showed that a diet high in unsaturated 
fat can reverse effects of IUGR on lung molecular changes, however, the effects 
of a diet high in saturated fats is unknown.  In this study we hypothesized that 
maternal HFD in combination with IUGR will decrease PPARγ2 and Setd8 mRNA 
and protein expression beyond that of IUGR alone. We hypothesize that 
H4K20Me in whole rat lung and at Exon 4 of the PPARγ gene will also be 
decreased by HFD and IUGR.  Sprague-Dawley rats were studied before and 
after alveolarization (prealveolarization and postalveolarization). Dams either 




for control rats. Half of each group (IUGR and control) were fed a regular diet 
while the other half were fed a HFD from preconception to the end of the study. 
Our study demonstrated that, HFD in combination with IUGR (HFD-IUGR) affects 
the PPARγ-Setd8 feedback loop in rat lung in a sex-specific manner. In male rat 
lung, HFD-IUGR resulted in disconnects in the PPARγ-Setd8 feedback loop.  
Furthermore, disconnects in the PPARγ-Setd8 feedback loop persisted beyond 
alveolarization. These novel findings suggest that male rat lungs are more 
susceptible to diet induced changes in the PPARγ-Setd8 feedback loop than 
female rat lungs. Further, these changes may make male IUGR rat lungs 
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Intrauterine Growth Restriction and Lung Development 
Up to 15% of pregnancies in the United States are complicated by 
intrauterine growth restricted (IUGR). IUGR is characterized by the failure of a 
fetus to reach its full genetic growth potential [1]. IUGR results in increased 
complications early on and into adult life [1-3]. Maternal malnutrition and/or 
reduced placental transport of nutrients are often underlying factors contributing 
to IUGR [2]. In the United States and other countries of affluence, IUGR is 
typically the result of poor maternal-fetal transfer as a consequence of maternal 
hypertension. IUGR as a result of maternal hypertension typically results in 
asymmetric growth restriction, with normal head size and reduced stature and 
weight [3]. 
In early life, premature newborns often suffer respiratory insufficiency 
requiring ventilator support. Approximately 5-15% of premature newborns are 
also IUGR [1]. IUGR infants that are born premature have an increased risk of 
chronic lung disease that persists into adulthood [3]. Bronchopulmonary 
dysplasia (BPD) is the most common complication of birth in preterm infants [4]. 
The National Institute of Child Health and Human Development diagnoses BPD if 
the infant remains oxygen dependent at 28 days of life [5-7]. Alternatively BPD 




postconceptional age [4, 7]. Low gestational age is a major predictor of BPD [4, 
8, 9], additionally IUGR has been identified as an independent risk factor for 
development of BPD [8, 10]. Many infants with BPD remain oxygen dependent 
for several months and are readmitted to the hospital within the first few years of 
life [6]. Children who were diagnosed with BPD in infancy, have lower lung 
volumes, decreased gas mixing efficiency and suffer more coughing/wheezing 
[6]. Lung impairment in BPD infants persists through adulthood [2, 4-6]. 
Lung impairment in BPD infants is associated with alterations to the 
structure of the lung.  In human lung, the saccular stage of lung development 
occurs in weeks 24-36 of gestation. Saccular development is characterized by 
thinning of epithelial cells, terminal saccular formation, and surfactant 
production[11]. The alveoli, gas exchanging units of the lung, are formed in utero 
and continuing developing new alveoli until 18-36 months of life in human infants 
[2, 11] . Lung growth after this point is mainly through enlargement of existing 
alveoli [2]. Lung development in rats occurs in stages similar to human 
development, as outlined in Figure 1. However in rats, saccular development 
continues through about postnatal day 5 and alveolar development occurs from 
about postnatal day 5 through day 30. 
In newborn rat pups, IUGR results in altered lung structure. Our lab has 
previously found that IUGR increases distal airspace wall thickness in the lung of 
newborn rat pups [12, 13].  IUGR decreases postnatal lung development in 
female pups[13]. In newborn female rat lung, the saccular walls are thicker in 







were observed in male pups. Alterations in lung structure likely contribute to the 
comorbidities associated with IUGR. 
The development of appropriate lung structure depends upon the precise 
regulation of expression of genes coordinating lung development.  Regulation of 




Epigenetic modifications are heritable alterations that effect gene 
expression but leave the DNA sequence unchanged [14].  In eukaryotic cells, 
DNA is packaged tightly in units known as chromatin, as shown in Figure 2. 
Chromatin consists of a series of subunits known as nucleosomes. Each 
nucleosome contains two copies of each of the four histone proteins: H2A, H2B, 
H3, and H4. DNA is tightly coiled around the histone proteins [15]. Methylation of 
histone proteins is one epigenetic modification that can occur in response to 
environmental changes.  
 
 






Methylation of lysine 20 on histone 4 (H4K20Me) is a histone modification 
of interest in lung development. H4K20Me is placed by the histone lysine 
methyltransferase Setd8. Setd8 is the only enzyme known to place the H4K20Me 
mark [16]. An important target of Setd8 is the peroxisome proliferator-activated 
receptor gamma (PPARγ) gene. Setd8 places the H4K20Me mark along the 
PPARγ gene, resulting in increased transcription of PPARγ mRNA and 
production the translated product, PPARγ protein [16]. At the same time, PPARγ 
is also a transcription factor that regulates the transcription of Setd8. Thus, 
     
      
    
Figure 2. Schematic of DNA Packaging.  














PPARγ and Setd8 act together in a feedback loop, see Figure 3 [16].  Of 




PPARγ and the Lung 
The ligand activated transcription factor, PPARγ has been identified as 
critical in pre- and postnatal lung development [17-21]. PPARγ isoforms are 
expressed in pulmonary inflammatory, mesenchymal and epithelial cells [18]. 
This study will focus on the PPARγ2 isoform. PPARγ knockout mice present with 
immature enlarged airspaces resulting in increased lung volume and decreased 
tissue resistance [18]. Additionally,  PPARγ is a necessary component in the 
parathyroid hormone related protein-driven epithelial-mesenchymal paracrine 









In order for PPARγ to function in lung development, agonists must be 
available to activate PPARγ. PPARγ agonists include the polyunsaturated fatty  
acid docosahexaenoic acid (DHA). Notably, DHA is reduced in serum of 
pregnant women with preeclampsia [23].   During the last trimester of pregnancy, 
maternal-placental transfer of DHA is increased but maternal plasma DHA is 




We previously demonstrated, in a rat model of IUGR, that IUGR 
decreases H4K20Me in newborn male rat lung relative to male control rat lungs. 
In addition, IUGR decreased H4K20Me in both male and female rat lung at Exon 
4 of the PPARγ gene. This decrease was found in conjunction with a decrease in 
levels of the PPARγ target gene, Setd8. In the same rat model of IUGR, rat pups 
are deficient in DHA at birth, and maternal DHA supplementation was found to 
restore DHA serum levels in the newborn infant, as well as restore H4K20Me on 
the PPARγ gene, as well as levels of Setd8 and PPARγ to that of a control 
animal [17].  
 
 
High Fat Diet and Lung Development  
While a diet high in unsaturated fats, specifically DHA, can ameliorate the 
effects of IUGR on H4K20Me, Setd8, and PPARγ, the typical Western diet is high 
in saturated fats (HFD). The effect of high fat diet throughout life increases risk of 




It is well-known that rates of obesity and overweight are on the rise in the 
United States and around the world. Among women of childbearing age, 24.5% 
are overweight and 23.0% are obese according to the 2002 National Survey of 
Family Growth [24]. This increase in obesity rates is often associated with the 
increased prevalence of a HFD diet. At the same time, rates of preeclampsia and 
gestational hypertension in the United States are increasing [25]. As previously 
discussed, these maternal vascular diseases are a common cause of IUGR. 
While the effects of obesity and HFD in general are associated with short- and 
longterm health effects for mother and child, it is unknown how HFD alone or in 




We hypothesize that, in rat lung, maternal HFD in combination with IUGR 
will decrease PPARγ2 and Setd8 mRNA and protein expression beyond that of 
IUGR alone, both before and after alveolarization. We hypothesize that 
H4K20Me in whole rat lung and at Exon 4 of the PPARγ gene will also be 













 IUGR was induced by uteroplacental insufficiency (UPI) in Sprague-
Dawley rats as previously described by our group [17, 19, 26-28]. In brief, on day 
19 of gestation (E19) dams were anesthetized with ketamine and xylanine and 
underwent bilateral uterine artery ligation. Control dams underwent the same 
anesthetized procedures at E19. Rat pups were delivered by c-section on E21.5, 
or day 0 (D0) of life. Rat pups were humanely killed and whole lungs removed 
and flash-frozen in liquid nitrogen and stored at -80C.  Day 21 (D21) rat pups 
were allowed to be delivered naturally at term and were nursed by their dams 
until time of tissue harvest at D21. All procedures were approved by the 
University of Utah Animal Care Committee and are in accordance with the 




Dams were fed either Regular diet (RD) or HFD prior to mating and during 
gestation through D21, weaning, Figure 4. RD rat chow consists of 29% kcals 
protein, 54% kcals carbohydrate, 17% kcals fat (primarily soybean oil and 0.04% 
wt/wt cholesterol), resulting in a caloric density of 3 kcal/g.  HFD is 16% kcals 




fat, 1% wt/wt cholesterol, and 0.5% wt/wt cholic acid) resulting in a caloric density 
of 4.3 kcal/g.  The two diets were fed to both UPI and control dams to create four 
groups as described in Table 1. 
 
 
Real-time RT PCR 
 PPARγ2 and Setd8 mRNA levels were evaluated via real-time RT- PCR in 
whole lung of D0 and D21 rats from each of the four groups, separated by sex. 
The housekeeping gene, GAPDH, was used as an internal control. The following 
primer/probe sets were used: PPARγ2–Rn00440940_m1, Setd8–
Rn01477383_g1(Applied Biosystems, Carlsbad, CA). GAPDH primer and probe 
sequences; Forward:CAAGATGGTGAAGGTCGGTGT; Reverse: 
CAAGAGAAGGCAGCCCTGGT; Probe: GCGTCCGATACGGCCAAATCCG. 
Total RNA was extracted from frozen Con, IUGR, HFD-Con, and HFD-IUGR lung 
using the RNAeasy Mini Kit (Qiagen, DB Biosciences, CA) according to 
manufacturer’s instruction. Total RNA was quantified using a NanoDrop 3300 
Fluorospectrometer (Thermo Scientific, Wilmington, DE). cDNA was synthesized 
 





Diet Initiation Conception IUGR Surgery
Delivery Weaning







using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, 
Foster CA) from 1µg of total RNA.  
All real-time PCR amplification, data acquisition and analysis were done 
using the 7900HT Real-time PCR system and SDS Enterprise Software (Applied 
Biosystems, Carlsbad, CA) using a 384-Well Optical Reaction Plate (Applied 
Biosystems, Carlsbad, CA). Taqman Universal PCR Mastermix (Applied 
Biosystems, Carlsbad, CA) was used in a 6µL reaction, performed in 
quadruplicate. Cycle parameters were: 50°C × 2 min, 95°C × 10 min, followed by 
40 cycles of 95°C × 15 sec and 60°C × 60 sec.  
 
 
Western Blotting or Immunoblotting 
Immunoblotting was used to determine levels of whole lung PPARγ2 and 
Setd8 protein in in Con, IUGR, HFD-Con, and HFD-IUGR rats. Total protein was 
isolated from whole lung tissue by homogenizing approximately 25mg tissue in 
Table 1  
Study Groups 
Group Surgery Diet 
Con Anesthesia only Regular diet prior to conception 
through weaning 
IUGR Bilateral uterine artery 
ligation 
Regular diet prior to conception 
through weaning 
HFD-   
Con 




Bilateral uterine artery 
ligation 






RIPA buffer (50mM Tris-HCl, pH 8.0, 150mM NaCl, 0.5% Na-deoxy-cholate, 1% 
NP-40 (Igepal), 0.1% SDS) and protease inhibitor cocktail (PIC) (Roche-
Complete Mini, Roche Applied Science, Indianapolis, IN); followed by 
centrifugation at 10,000g, 4°C, 15 minutes. Supernatants were collected and 
stored at −80°C until use. Protein was assayed in triplicate for protein 
concentration using the bicinchoninic acid protein assay kit (Pierce 
Biotechnology, Rockford, IL).Total protein (25 µg) was loaded and separated by 
Nu-Page 10% Bis-Tris Midi Gel (Novex by Life Technologies, Grand Island, NY) 
at 150 V for 60 minutes. After gel electrophoresis, proteins were transferred to 
PVDF membranes (Milli-pore, Billerica, MA) at 4°C for 1 hour at 100 V. 
Membranes were then blocked in  5% milk TBS-T for 1 hour then washed 
multiple times in 1X TBS-T. After blocking, bound proteins were exposed to 
antibodies against GAPDH (Abcam, Cambridge, MA) 1:5,000 in 5% milk with 
PPARγ 1:500 in 5% milk or with Setd8 1:8000 in 5% milk. Blots were incubated 
overnight at 4°C. After multiple wash steps in TBS-T, membranes were probed 
with appropriate secondary antibody: antirabbit IgG antibody (Cell Signaling 
Technology, Danvers, MA) or bovine antigoat (Santa Cruz Biotechnology, Dallas, 
Texas) for 1 hour at room temperature. After multiple wash steps in TBS-T, 
antibody signals were detected with Western Lighting enhanced 
chemiluminescence (PerkinElmer Life Sciences, Boston, MA) and quantified 
using an Image Station 2000R (Eastman Kodak/SIS, Rochester, NY). GAPDH 






Chromatin Immunoprecipitation  
A revised ChIP protocol, based on the methods of Farnham and 
Bomstztyk [29], was used to investigate  the levels of histone modifications along 
the PPARγ gene at the following positions: 5’ region of promoter 1 ( 5′ of P1), 
promoter 1 ( P1), promoter 2 (P2), Exon 4 and at the 3′ untranslated region (3’ 
end), depicted in Figure 5. The five positions were chosen because they each 
represent areas of the PAPRγ gene subject to different transcriptional regulatory 
mechanisms.  
Briefly, chromatin isolation from male and female whole lung (190–280 
mg) was performed as follows; tissue was fixed in 1% formaldehyde for 10 
minutes at room temperature, the reaction was stopped by the addition of glycine  
to a final concentration of 125 mM. Samples were centrifuged, washed twice with 
phosphate buffered saline (PBS) and resuspended in PBS with added PIC at  
manufacture’s recommended concentration (Roche-Complete Mini, Roche 
Applied Science, Indianapolis, IN). After centrifugation, cell pellets were 


















PIC and dounced on ice using a tight pestle. After centrifuging, pelleted nuclei 
were resuspended in nuclei lysis buffer (50 mM Tris-Cl, pH 8.1, 10 mM EDTA, 
1% SDS) with PIC, incubated for 20 minutes on ice and split into aliquots of 
approximately 200 μl (in 1.5 ml tubes) for sonication. Sonication was performed 
on ice using a Fisher Scientific Model 100 sonicator with microtip attachment 
(Fisher Scientific, Pittsburgh, PA). Each sample was pulsed 10 times with the 
micotip placed near the base of the tube and returned to ice, this was repeated a 
total of eight times. After centrifuging, chromatin containing supernatants for each 
of the four samples were frozen at −80°C. 
Immunoprecipitation (IP) were performed as previously [29] using anti-
H4K20Me (NB 21-2088), A nontranscribing intergenic region was used as a 
control. Primers sequences used for RT-PCR of IP DNA are listed in Table 2.  
 
 
Statistical Analysis  
Test groups were compared to the corresponding sexmatched Con. 






Table 2  
Primer/probe Sets for ChIP RT-PCR 




5′ of P1 For: 5′ TCGACGGCTTTCTGAATGTG 
Rev: 5′ CTTGCCCTCTTTCAGCTCTTTC 
Probe: 5′ATCTTTAGGACAGATCATG 
 
P1 For: 5′ 
AAAAACAAACTTCTGCGTGACAGT 
Rev: 5′ GGTCCCACGTTCCTCAGACA 
Probe: 5′ AGGGCACCAGCCGG 
 
P2 For: 5′ CCAAGTCTTGCCAAAGAAGCA 
Rev: 5′ 
GATTGAGAGCCAGCTGTGACAA 
Probe: 5′ ACAGCATTATGACACACCAT 
 
Exon 4 For: 5′ CCATCAGGTTTGGGCGAAT 
Rev: 5′ GATCTCCGCCAACAGCTTCT 
Probe: 5′ CCACAGGCCGAGAAG 
3′ End  
For: 5′ CGCCAAGGTGCTCCAGAA 
Rev: 5′ CTGCACGTGCTCTGTGACAA 





















D0, Prealveolarization  
D0 PPARγ2 mRNA and Protein  
In male D0 rat lung, HFD-Con (p=0.039) and HFD-IUGR (p=0.022) 
decreased PPARγ2 mRNA relative to Con (Figure 6A). However, in male D0 rat 
lung PPARγ2 protein levels were unaffected by either IUGR or HFD-Con (Figure 
6B). In female D0 rat lung, IUGR (p<0.0001), HFD-Con (p=0.0002), and HFD-
IUGR (p=0.0003) decreased PPARγ2 mRNA levels relative to control (Figure 
6C). In female D0 rat lung, IUGR (p=0.0128) and HFD-Con (p=0.0053) 
decreased PPARγ2 protein levels, relative to control (Figure 6D). The 
combination of HFD-Con and IUGR did not significantly alter PPARγ2 protein 
levels in female rat lung. 
 
 
D0 Setd8 mRNA and Protein  
In male D0 rat lung, HFD-Con (p=0.0281) and HFD-IUGR (p=0.0040) 






(p=0.0014) and HFD-IUGR (p<0.0001) increased Setd8 protein relative to Con. 
HFD-IUGR (p=0.0181) increased Setd8 protein relative to HFD-Con (Figure 7B).  
In female D0 rat lung, IUGR (p=0.0068) and HFD-IUGR (p=0.0133) 
decreased Setd8 mRNA relative to Con (Figure 7C). HFD-IUGR (p=0.0347) 
decreased Setd8 mRNA relative to HFD-Con. In female D0 rat lung, IUGR 
(p=0.0009) and HFD-Con (p=0.0190) decreased Setd8 protein relative to Con 
(Figure 7D).  
 
Figure 6. D0 PPARy mRNA and Protein. 
A) Male D0 PPARγ2 mRNA levels relative to GAPDH. B)Male D0 PPARγ2 protein 
levels  relative to GAPDH. C) Female D0 PPARγ2 mRNA levels relative to GAPDH. 
D) Female D0 PPARγ2 protein levels relative to GAPDH. *Denotes statistical 











































































































































D0 H4K20Me  
H4K20Me was altered along the PPARγ gene, Figure 8. In male D0 rat 
lung, HFD-Con (p=0.0088) and HFD-IUGR (p=0.0454) both decreased H4K20Me 
in the 5’ region of Promoter 1 and, Promoter 1 (p<0.0001) and in Promoter 2 
(p<0.001). HFD-IUGR (p=0.0317) reduced H4K20Me in the 3’ untranslated 
region. No changes where observed Exon 4 of the PPARγ gene in D0 male rat 
lung.  
In female D0 rat lung, HFD-Con (p=0.0086) decreased H4K20Me in the 5’ 
promoter region. HFD-Con and HFD-IUGR decreased H4K20Me in Promoter 1  
 
Figure 7. D0 Setd8 mRNA and Protein 
A) Male D0 Setd8 mRNA levels relative to GAPDH. B) Male D0 Setd8 protein 
levels  relative to GAPDH. C) Female D0 Setd8 mRNA levels relative to 
GAPDH. D) Female D0 Setd8 protein levels relative to  GAPDH. *Denotes 
statistical significance relative to sex-matched Con, p<0.05. ^Denotes 













































































































































Figure 8. D0 H4K20Me Along PPARγ 
Table Legend: 1=Con, 2=IUGR, 3=HFD-Con, 4=HFD-IUGR 
# relative to nontranscribing intergenic region 











































































































































(p<0.0001 and p<0.0001, respectively) and in Promoter 2 (p=0.0285 and 
H4K20Me in Exon 4 (p=0.0261)).  The 3’ untranslated region was unaffected by 
the test groups.   
 
 
D21, Postalveolarization  
 
D21 PPARγ2 mRNA and Protein  
In male D21 rat lung, IUGR (p=0.0035) and HFD-Con (p=0.0010) 
decreased PPARγ2 mRNA relative to Con (Figure 9A). HFD-IUGR (p=0.0940) 
did not alter PPARγ2 mRNA relative to Con. However, in male D21 rat lung 
PPARγ2 protein levels were not affected by IUGR, but HFD-Con (p=0.0198) and 
HFD-IUGR (p=0.0016) decreased PPARγ2 protein relative to Con (Figure 9B). In 
female D21 rat lung, only HFD-IUGR (p=0.0364) decreased PPARγ2 mRNA 
levels relative to Con (Figure 9C). In female D21 rat lung, IUGR (p<0.0001) 
increased PPARγ2 protein levels, relative to Con (Figure 9D).  
 
 
D21 Setd8 mRNA and Protein  
In male D21 rat lung, Setd8 mRNA was unchanged in all groups relative to 
Con (Figure 10A). IUGR (p=0.0130) and HFD-IUGR (p=0.0001) increased Setd8 
protein relative to Con. HFD-IUGR (p=0.0032) increased Setd8 protein relative to 
HFD-Con (Figure 10B). In female D21 rat lung, Setd8 mRNA was unchanged in 
all gropus relative to Con (Figure 10C). Accordingly in female D21 rat lung, Setd8 






H4K20Me was altered along the PPARγ gene, Figure 11. In male D21 rat 
lung, HFD-Con and HFD-IUGR decreased H4K20Me in the 5’ promoter region 
(p=0.0042 and p=0.0010 respectively), in Promoter 1 (p=0.0049 and p=0.0002, 
respectively), and in Promoter 2 (p=0.0379 and p=0.0008, respectively). In male 
D21 rat lung HFD-IUGR decreased H4K20Me compared to Con (p=0.0024) and 
HFD-Con (p=0.0008) at Exon 4.  In male D21 rat lung, HFD-IUGR decreased  
 
Figure 9. D21 PPARy mRNA and Protein 
A) Male D21 PPARγ mRNA levels relative to GAPDH. B) Male D21 PPARγ 
protein levels  relative to GAPDH. C) Female D21 PPARγ mRNA levels 
relative to GAPDH. D) Female D21 PPARγ protein levels relative to GAPDH. 









































































































































































































































































H4K20Me in the 3’ untranslated region compared to Con (p=0.0336) and HFD- 
IUGR (p=0.0289). 
In female D21 rat lung, neither IUGR or HFD, alone or in combination, 
changed H4K20Me in the 5’ promoter region, Promoter 1, Promoter 2, Exon 4 or 
the 3’ untranslated region compared to Con.  In female D21 rat lung, HFD-IUGR  
(p=0.0437) decreased H4K20Me in Promoter 1 compared to HFD-Con.  In 
female D21 rat lung, HFD-IUGR (p=0.0440) decreased H4K20Me in the 3’ 








































































































































Figure 10. D21 Setd8 mRNA and Protein 
A) Male D21 Setd8 mRNA levels relative to GAPDH. B) Male D21 setd8 
protein levels  relative to GAPDH. C) Female D21 Setd8 mRNA levels relative 
to GAPDH. D) Female D21 Setd8 protein levels relative to GAPDH. *Denotes 











































































































































































































































































Figure 11. D21 H4K20Me Along PPARγ 
Table Legend: 1=Con, 2=IUGR, 3=HFD-Con, 4=HFD-IUGR 
# relative to nontranscribing intergenic region 
*Denotes statistical significance relative to sex-matched Con, p<0.05 
^Denotes statistical significance relative to sex-matched HFD-Con, p<0.05 
* *








































































































































Our study revealed important and novel findings. HFD in combination with 
IUGR (HFD-IUGR) alters the PPARγ-Setd8 feedback loop in rat lung in a sex-
specific manner. In male rat lung, HFD-IUGR disrupts interactions between 
components of the PPARγ-Setd8 feedback loop. Importantly, the effects of HFD-
IUGR on the PPARγ-Setd8 feedback loop in male rat lung persist beyond 
alveolarization. These novel findings suggest that male rat lungs are more 
susceptible to diet induced changes in the PPARγ-Setd8 feedback loop than 
female rat lungs. Further, these changes may make male IUGR rat lungs 
susceptible to lung injury over the longterm. 
HFD-IUGR affects the PPARγ-Setd8 feedback loop differently in male and 
female rat lung.  In female rat lung, HFD-IUGR reduced PPARγ2 and Setd8 
mRNA expression, and reduced H4K20Me on the PPARγ gene.  These results 
suggest that in female HFD-IUGR rat lung, the PPARγ-Setd8 feedback, while 
reduced in magnitude compared to female control lung, maintains appropriate 
interactions between components of the feedback loop. These HFD-IUGR data, 
in female rat lung, are consistent with our previous study of IUGR alone. This 
suggests that in female rat lung, HFD does not alter the response to IUGR. 
Furthermore, significant effects of IUGR and HFD-IUGR, in female rat lung, do 




However, in male rat lung, HFD with or without IUGR, resulted in an 
unanticipated disconnect in the PPARγ-Setd8 feedback loop. HFD-IUGR 
decreased PPARγ2 expression as expected in newborn male rat lung. However 
this was associated with twofold increase in Setd8 mRNA and protein compared 
to sex matched controls. Despite the increased levels of Setd8 protein, HFD-
IUGR reduced H4K20Me along the PPARγ gene in newborn male rat lung. This 
suggests that in males a HFD interferes with the interactions between PPARγ2 
expression, Setd8 expression and placement of the H4K20Me mark on the 
PPARγ gene. One question raised by the observation of high Setd8 levels with 
low H4K20Me is why is not Setd8 methylation of the PPARγ gene reflective of 
these increased levels? While the present study was not designed to investigate 
this mechanism, potential factors can be hypothesized.  
A decrease in H4K20Me under conditions of increased Setd8, could be 
the result of several situations. First, Setd8 may not be able to place the 
H4K20Me mark because another chromatin modifying enzyme may have placed 
a different mark on H4K20 preventing access to Setd8. Additionally, HFD-
induced alterations elsewhere in the histone code may impact the chromatin 
structure and prevent Setd8 from accessing the H4K20. Expression of other 
chromatin modifying enzymes known to impact Setd8 may be effected by a HFD. 
For example, overexpression of the di-/tri- methyltrnasferase, SUV4-20H, results 
in decreased levels of H4K20Me [30]. Alternatively, Setd8 may require 
assistance from other transcription factors or chromatin modifying enzymes that 




that Setd8 is still placing the mark effectively but its turnover is increased. The 
histone demethylase PHT8 can remove the H4K20Me placed by Setd8 [30], and 
it is unknown how HFD effects this histone demethylase. 
In this study, we examined the effects on H4K20Me on the PPARγ gene, 
however, we did not examine how other target genes of Setd8 are affected. 
Setd8 function is indicated in the regulation of wnt signaling and in the 
transcriptional regulation of genes important in cellular differentiation. Wnt  
signaling and cellular differentiation are important to proper lung development 
[31]. 
 A novel finding of this study is that the molecular changes elicited by HFD-
IUGR persist postalveolarization in male rat lung. At D21HFD-IUGR rat lung is 
characterized by reduced PPARγ protein and increased Setd8 protein. Again, 
despite increased Setd8 protein, HFD-IUGR reduces H4K20Me along the PPARγ 
gene.  The effects of decreased H4K20Me along the PPARγ gene on lung 
structure and function are currently unknown. However, we speculate that a 
persistent change in the level of expression of PPARγ and in the epigenetic 
H4K20Me profile of the PPARγ gene, will result in persistent changes in lung 
structure and function. These changes in lung structure and function may make 
the male rat lung more susceptible to lasting effects of injury. In fact, our lab has 
demonstrated that IUGR induced decreased PPARγ and H4K20me is associated 
with an exacerbated response to postnatal lung injury, in male rat lung but not 




Sex differences are not always investigated in early developmental studies 
because these processes are often viewed as common to both male and female 
fetuses. However, recent research in our lab has shown that IUGR sex 
specifically alters expression of aromatase, an estrogen synthase,  in newborn 
rat lung in association with sex specific changes in local estrogen:testosterone 
ratios [33].  Local changes in estrogen:testosterone ratios may be the initiator of 
sex specific differences in gene expression in the rat lung. Further studies are 
needed to investigate the presence of estrogen and testosterone response 




Strengths and Limitations 
Our study is not without limitations. Firstly, we did not characterized lung 
structure and function in our rat model. Our molecular observations show that 
expression of genes important for lung development are dysregulated, implying 
that lung structure, and thus function, may also be impaired by HFD. It will be 
important for future studies to examine lung structure and function in HFD and 
HFD-IUGR rats.  Caution should be taken when extrapolating data obtained in 
the rat, to human findings. However, lung development in both humans and rats 
follow the same pathway, differing only in timing relative to birth. One advantage 
of this difference is that the newborn rat lung is developmentally equivalent to a 




born preterm. This developmental timing allows us to evaluate the immature lung 
in the newborn rat, without the complications of prematurity.  
Our lab has previously shown that IUGR, without alterations in diet, 
decreases PPARγ mRNA and protein levels in both male and female newborn rat 
lung [17]. Our current study is consistent with the previous work for female rat 
lung.  However, in the current study, newborn male rat lung changes in PPARγ 
and Setd8, while in a similar direction, were not statistically significant. Failure to 
obtain statistical significance in male rat lung PPARγ and Setd8 decreases in the 
current study is likely a result of insufficient power resulting from too few 




Alterations in lung development resulting from prenatal insult increase the 
risk of chronic comorbidities and early mortality. Many women of childbearing 
age are at an increased risk of developing preeclampsia during pregnancy due to 
prepregnancy overweight and obesity. As a result, their unborn children are at an 
increased risk of being IUGR. Additionally, many women of child bearing age in 
the United States enjoy the typical Western diet which is commonly described as 
a HFD, placing their children at risk for exposure to a HFD in utero. Because of 
the high potential of prenatal exposure to IUGR with a HFD, it is important 
to understand how these two unique prenatal insults act together. 
Understanding how HFD and IUGR cause complications and alter lung 




deleterious effects. Current research is investigating potential markers for 
intrauterine growth restriction which may allow for interventions in utero, 
preventing the deleterious effects of IUGR and/or HFD [34, 35].  Increased 
understanding for the role of diet in lung development may also influence 
recommendations for ‘catchup’ growth in early life when lung development is still 
occurring and a high calorie HFD is often prescribed.  
 In conclusion, our study provides novel evidence that male and female rat 
lung responded differently to a HFD and HFD-IUGR. This suggests that male and 
female lungs are programmed to respond differently to injury and would likely 
respond differently to treatment. As we continue to extend upon the 
understanding of prenatal development it is necessary to evaluate differences 
between the sexes. Clinicians should be aware that sex may impact response to 
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